Search Results 261-270 of 10437 for Cholangitis
Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis. J Hepatol. 2026 Feb; 84(2):275-283. Epub 2025 Oct 03.
Dose Response Study Of GSK2330672 For The Treatment Of Pruritus In Patients With Primary Biliary Cholangitis ... cholangitis (PBC). Participants will be ...
The purpose of this study is to learn more about volixibat for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to ...
... cholangitis in the present can look forward to a brighter future. It's both a mouthful and a ruthless condition: primary sclerosing cholangitis. An abnormal ...
A Study To Evaluate The Safety, Tolerability, And Effectiveness Of Cilofexor In Non-Cirrhotic Adults With Primary Sclerosing Cholangitis ... cholangitis (PSC).
Primary sclerosing cholangitis (PSC) causes inflammation and scarring of the bile ducts. This rare liver disease is often accompanied by inflammatory bowel ...
Cholangiocarcinoma, Primary sclerosing cholangitis, Hepatitis C, Hepatitis B, Hepatocellular carcinoma, Primary biliary cholangitis, Nonalcoholic fatty ...
Mayo Clinic is a pioneer of liver transplantation for cholangiocarcinoma in the setting of primary sclerosing cholangitis (PSC).
The purpose of this study is to assess the safety and efficacy of GKT13783 in patients with Primary Biliary Cholangitis (PBC) who are taking a stable dose of ...
MELD calculator · The Updated Natural History Model for Primary Biliary Cholangitis · GALAD Calculator · Probability of Mortality Following Transjugular ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.